Year archive

Immunotech Biopharm Ltd — 2023 filings

All 35 regulatory filings released by Immunotech Biopharm Ltd (6978) in 2023, sourced directly from the official regulator.

35 Filings

2023 Period

2023 filings (35)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-04	English
VOLUNTARY ANNOUNCEMENT RECEIPT OF THE ACCEPTANCE NOTICE FOR THE INVESTIGATIONAL NEW DRUG APPLICATION FOR THE aT19 INJECTION Regulatory Filings	2023-11-24	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE PHASE I CLINICAL TRIAL FOR THE DENOCABTAGENE CILOLEUCEL INJECTION Regulatory Filings	2023-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Regulatory Filings	2023-10-06	English
2023 INTERIM REPORT Regulatory Filings	2023-09-21	English
VOLUNTARY ANNOUNCEMENT EAL WAS GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR TREATMENT OF LIVER CANCER BY THE CENTER FOR DRUG EVALUATION Regulatory Filings	2023-09-05	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-05	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Regulatory Filings	2023-08-27	English
ANNOUNCEMENT OF THE INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023 Regulatory Filings	2023-08-27	English
APPOINTMENT AND RESIGNATION OF DIRECTORS Regulatory Filings	2023-08-27	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Regulatory Filings	2023-08-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-02	English
THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2023-05-25	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023 Regulatory Filings	2023-05-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 25 MAY 2023 Regulatory Filings	2023-04-25	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2023-04-25	English
PROPOSED RE-ELECTION OF RETIRING DIRECTORS, PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND Regulatory Filings	2023-04-25	English
2022 ANNUAL REPORT Regulatory Filings	2023-04-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-04	English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION Regulatory Filings	2023-03-26	English
APPOINTMENT AND RESIGNATION OF DIRECTORS Regulatory Filings	2023-03-26	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022 Regulatory Filings	2023-03-24	English
PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE THIRD MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2023-03-24	English
VOLUNTARY ANNOUNCEMENT THE CLINICAL APPROVAL FOR THE DENOCABTAGENE CILOLEUCEL INJECTION Regulatory Filings	2023-03-21	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-03	English
COMPLETION OF ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE Regulatory Filings	2023-02-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-02-03	English
EXTENSION OF LONG STOP DATE IN RELATION TO THE SUBSCRIPTION AGREEMENT Regulatory Filings	2023-01-26	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 11 JANUARY 2023 Regulatory Filings	2023-01-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-01-06	English